Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months

INTRODUCTION: Understanding how spike (S)-, nucleoprotein (N)-, and RBD-directed antibody responses evolved in mild and asymptomatic COVID-19 in Africa and their interactions with SARS-CoV-2 might inform development of targeted treatments and vaccines. METHODS: Here, we used a validated indirect in-...

Descripción completa

Detalles Bibliográficos
Autores principales: Serwanga, Jennifer, Ankunda, Violet, Sembera, Jackson, Kato, Laban, Oluka, Gerald Kevin, Baine, Claire, Odoch, Geoffrey, Kayiwa, John, Auma, Betty Oliver, Jjuuko, Mark, Nsereko, Christopher, Cotten, Matthew, Onyachi, Nathan, Muwanga, Moses, Lutalo, Tom, Fox, Julie, Musenero, Monica, Kaleebu, Pontiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060567/
https://www.ncbi.nlm.nih.gov/pubmed/37006272
http://dx.doi.org/10.3389/fimmu.2023.1152522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060567/
https://www.ncbi.nlm.nih.gov/pubmed/37006272
http://dx.doi.org/10.3389/fimmu.2023.1152522

Ejemplares similares